1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 46 Hits
  • Search Condition : Filter (MeSH = Tumor Burden / drug effects)
Species Resource Title
Human and Animal Cells MDA-MB-453(RCB1192) Therapeutic effects of autologous lymphocytes activated with trastuzumab for xenograft mouse models of human breast cancer.
Human and Animal Cells OP9(RCB1124) , OP9/G-DLL1(RCB2925) In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Human and Animal Cells HSC-2(RCB1945) A landmark in drug discovery based on complex natural product synthesis.
Human and Animal Cells NUGC-4(RCB1939) The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile.
Human and Animal Cells NIH/3T3(RCB2767) Development of nanoparticles derived from corn as mass producible bionanoparticles with anticancer activity.
Human and Animal Cells T98G(RCB1954) Targeting JNK for therapeutic depletion of stem-like glioblastoma cells.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
Human and Animal Cells HuH-7 HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.
Human and Animal Cells Colon-26(RCB2657) A novel nitric oxide-based anticancer therapeutics by macrophage-targeted poly(l-arginine)-based nanoparticles.
Human and Animal Cells LM8(RCB1450) Combination of ultrasound and bubble liposome enhance the effect of doxorubicin and inhibit murine osteosarcoma growth.
Human and Animal Cells LC-2/ad(RCB0440) Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma.
Human and Animal Cells PK-59(RCB1901) PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
Human and Animal Cells LM8(RCB1450) Radiation Enhances the Efficacy of Antitumor Immunotherapy with an Immunocomplex of Interleukin-2 and Its Monoclonal Antibody.
Human and Animal Cells Li-7(RCB1941) ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma.
Human and Animal Cells LM8(RCB1450) Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma.
Human and Animal Cells 8505C(RCB2103) , 8305C(RCB1909) Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroid cancer in orthotopic SCID mouse models using small‑animal FDG‑PET/CT.
Human and Animal Cells A549(RCB0098) The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo.
Human and Animal Cells LLC(RCB0558) Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity.
Human and Animal Cells HCT116(RCB2979) , MKN45(RCB1001) Dimethyl Fumarate Attenuates Oxaliplatin-Induced Peripheral Neuropathy without Affecting the Anti-tumor Activity of Oxaliplatin in Rodents.
Human and Animal Cells A549 , Hep G2 , HeLa Synthesis and antitumor activity of novel pyridinium fullerene derivatives.